IMS Capital Management’s Zimmer Biomet ZBH Stock Holding History

IMS Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-540	Closed	-$69K	–	354
2018 Q3	$69K	Buy	+540	New	+$64.2K	0.05%	172
2016 Q4	–	Sell	-5,261	Closed	-$664K	–	153
2016 Q3	$664K	Sell	5,261 -82	-2%	-$10.1K	0.77%	46
2016 Q2	$624K	Sell	5,343 -2,163	-29%	-$245K	0.73%	48
2016 Q1	$777K	Hold	7,506	–	–	0.94%	41
2015 Q4	$748K	Hold	7,506	–	–	0.92%	42
2015 Q3	$684K	Hold	7,506	–	–	0.82%	48
2015 Q2	$796K	Buy	7,506 +1	+0%	+$111	0.95%	38
2015 Q1	$856K	Buy	7,505 +52	+0.7%	+$5.93K	0.96%	39
2014 Q4	$821K	Hold	7,453	–	–	0.94%	37
2014 Q3	$728K	Sell	7,453 -1,957	-21%	-$192K	0.84%	42
2014 Q2	$949K	Sell	9,410 -1,029	-10%	-$100K	1.03%	23
2014 Q1	$959K	Hold	10,439	–	–	1.13%	23
2013 Q4	$944K	Hold	10,439	–	–	1.19%	17
2013 Q3	$832K	Buy	10,439 +109	+1%	+$8.58K	1.15%	23
2013 Q2	$752K	Buy	+10,330	New	+$772K	1.08%	31

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IMS Capital Management's ZBH Position: Q4 2018 in Review

IMS Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 540 shares — an estimated $69K sold.

IMS Capital Management first reported a position in ZBH in Q2 2013 and held it in 15 quarters. The position peaked at $959K in Q1 2014. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

IMS Capital Management reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
IMS Capital Management sold 540 Zimmer Biomet shares in Q4 2018, an estimated $69K.
IMS Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 15 quarters.
IMS Capital Management's Zimmer Biomet position peaked at $959K in Q1 2014.
871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on IMS Capital Management's 13F filing for Q4 2018, filed 7 Feb 2019.